Li Jie

Professional Biography

Dr. Li Jie is Chief Physician in Gastrointestinal Oncology at Peking University Cancer Hospital, Beijing. Li serves as Vice Chairman, Neuroendocrine Tumor Committee, Chinese Anti-Cancer Association (CACA). Clinical expertise includes Gastric cancer, Colorectal cancer, Pancreatic cancer, Gastrointestinal stromal tumors (GIST). Key investigator in the SANET-ep Phase 3 randomized trial of surufatinib for advanced extrapancreatic neuroendocrine tumors (Lancet Oncology 2020) — a landmark trial that established surufatinib as the first Chinese-developed drug approved for neuroendocrine tumor treatment. Visiting Scholar, Abramson Cancer Center, University of Pennsylvania, USA. Internationally trained: Abramson Cancer Center (UPenn), Barcelona, and UCLA visiting fellowships.